This chapter is about pain perceived to be in the male pelvis—the pelvic pain syndromes. For the purpose of this chapter, the pelvis is considered as the anatomical bony pelvis and the structures both within and adjacent to it, including the male external genitalia, nervous system structures, and soft tissue/muscular structures, that is, the pelvis in its broadest sense. Although this chapter focuses primarily on the male urogenital pelvic pain syndromes, the importance of other systems, particularly the musculoskeletal, nervous, and other viscera, is emphasized when appropriate.
There are many well-recognized, well-defined pathologies that may result in pain perceived within the male urogenital system, such as infections of the organs; infiltration of somatic, visceral, and nervous tissue by cancer; and referred sensations from the musculoskeletal system. However, for less defined pathologies, the mechanisms underlying the pains have been less widely appreciated outside of pain medicine. The mechanisms for this second group, which is probably the majority of male pelvic pain patients, involve neurologic mechanisms—in particular, central sensitization that may involve the whole neuraxis. These are the primary chronic pain syndromes.
The latest classification approaches have taken this dichotomy of mechanisms into account. To emphasize the differences, those conditions where the main mechanisms are related to central sensitization are known as the pelvic pain syndromes, and they are considered separately from those conditions with ongoing nociceptive, acute pain mechanisms, such as those due to chronic infection. Pelvic pain syndromes are defined by their symptoms and signs and typically by the presence of sensitization, including visceral hypersensitivity, viscerovisceral hypersensitivity (i.e., cross-organ sensitization), and viscerosomatic hypersensitivity (e.g., expanded area of referred sensation and/or increased sensitivity to palpation). Often, an important part of the process of diagnosing the pelvic pain syndromes is excluding other pathologies.
Classification of the pelvic pain syndromes involves terminology, phenotyping, and taxonomy. The phenotype describes the condition in terms of symptoms, signs, and, where possible, mechanisms. Incorporating the phenotype into a hierarchy of phenotypes produces a taxonomy that allows comparisons between phenotypes. This approach enables appropriate prognosis and treatment. The terminology used can be very emotive, and careful description of the meaning of the terms is often required. The classification of pelvic urogenital pain has been rapidly evolving over the past 15 years and is likely to continue to do so.
1,2,3,4,5,6,7,8,9 This ongoing change in classification not only reflects our increasing knowledge but also has caused problems for research and evidence-based treatment. The classification will be covered in depth as it is the key to understanding male pelvic pain syndromes.
The central nervous system mechanisms of central sensitization and the psychological responses that result in the chronic pain syndrome are covered in other chapters within this book; those processes that are specific to urogenital pain are expanded on in this chapter. There are some obvious differences between the male and female urogenital systems that will result in specific pain syndromes; however, it is important to recognize that there is much overlap as well. Those differences due to gender and sex are covered in
Chapter 7.
This chapter supports that in most men with chronic pain perceived in the pelvic organs, the cause of the pain is not often due to classical pathologies of infection or infiltration but more commonly due to chronic pain mechanisms involving a number of systems with referred pain, sensory and functional consequences (e.g., urinary and fecal incontinence, urge and urgency, urinary hesitance, impotence), and chronic pain psychological responses.
8
Taxonomy and Phenotyping Chronic Pelvic Pain
A realization has occurred that pain perceived within the pelvis may be associated with classical pathology of the pelvic structures or that it may result secondary to central nervous system pain mechanisms. It is the latter conditions that this chapter primarily concentrates on.
CLASSICAL PATHOLOGIES
Classical pathologies include infection, inflammation, degeneration, neoplastic, and autoimmune mechanisms of any of the pelvic or adjacent pelvic structures (referred pain). In the case of classical pathology, chronic persistent pain is the result of ongoing local pathology, persistent nociceptor activation with peripheral sensitization, and possibly a central sensitization process. Treatment will primarily be focused on managing the underlying pathology and the use of analgesics where required. Removing the peripheral cause should resolve the pain.
PELVIC PAIN SYNDROMES AND NONPELVIC PAIN SYNDROMES
Most of the recent attempts at classification, taxonomy, and phenotyping have tried to separate out the classical pathologies from those conditions without classical pathology that have become known as the pelvic pain syndromes.
3,7,10 The pelvic pain syndromes are the conditions where there is no peripheral pathology maintaining the pain experience (peripheral stimuli may however maintain the central sensitization). In its attempt to separate out the pelvic pain syndromes from those with a nociceptive cause, the European Association of Urology (EAU) in their 2004 classification system called those conditions associated with classical pathology as “well-defined” conditions and the European Society for the Study of Interstitial Cystitis (ESSIC) called them “confusable diseases.”
3,10 Both of those terms have a disadvantage. The term
well-defined suggests that the pain syndromes are poorly defined; however, as an understanding of chronic pain mechanisms (including visceral pain mechanisms) and central sensitization develops, this is clearly not the case. ESSIC used the term
confusable to separate out the pain syndromes from those conditions that they might be confused with, a very difficult concept. In future classifications, one way forward is that chronic pelvic urogenital pain syndromes will become a differential diagnosis with the classical pathologies, and the taxonomy will be divided into pelvic pain syndromes and nonpelvic pain syndromes.
11 The World Health Authority working with the International Association for Pain in ICD11 is using the term primary chronic pain. The emphasis is thus on the pelvic pain syndromes, which is probably correct as in most individuals classical disease processes are not present.
Table 65.1 illustrates the division of
chronic pelvic pain into pain syndromes and nonpelvic pain syndromes.
Table 65.2 provides the definitions for chronic pelvic pain and the pelvic pain syndromes. The latest World Health Organization
International Classification of Diseases, 11th Revision, recognizes pain as a condition in its own right, although uses some outdated terminology. The International Continence Society has tried by working with other published guidelines to achieve international consensus. However, their “Standard for Terminology” did not have any pain medicine representation and reverted to older terminology in places.
12 It will take a lot more time for consensus to be reached.
This chapter uses the EAU and International Association for the Study of Pain (IASP) accepted classifications, which the author was involved in.
Male Urogenital Pain Syndromes
Traditionally, pelvic pain conditions would be classified into those of the male, female, or both. This approach is currently being reconsidered, as the mechanisms discussed earlier may be common to both sexes with the only difference being the sex organ that the pain is perceived in. However, as there has been a lot of research looking at the end-organ pain syndromes and their treatment, this is summarized in the following text as relevant for the male.
MALE-SPECIFIC PELVIC PAIN SYNDROMES
The unique male pelvic pain syndromes are those where the pain is
perceived in the male sex organs.
Table 65.3 summarizes these conditions. The definitions serve to emphasize that classical pathologies are absent.
SUBCLASSIFICATION OF THE PELVIC PAIN SYNDROMES BY ORGAN
Much discussion has been had about whether it is appropriate to divide the pelvic pain syndromes by the end organ that the pain is perceived in. Many would rather maintain a more generic approach and keep to the term
pelvic pain syndrome to cover all pains perceived within the pelvis and not associated with a classical pathology. The EAU approach (see
Table 65.1) uses a progressive step-by-step approach to classification.
3,11 That is, classification starts at the left end of the table if pain is perceived within the pelvis or the external sex organs. Further subclassification only occurs if there are distinct localizing factors within an end organ. Such an approach to taxonomy is very similar to that used to classify life and the animal and plant kingdoms. For instance, we would progress from animal to mammal to elephant only as the evidence allowed. The primary localizing factor for pelvic pain is pain produced by local physical stimulation, such as palpation. If an end organ is clearly associated with the area of perceived pain, then the pain may be labeled with that end organ name as in
Table 65.1. If more than one organ is deemed to be involved, then either two names may be given to the condition, or it may be more appropriate to consider the pain in more generic terms as a pelvic pain syndrome.
THE IMPORTANCE OF TAXONOMY AND PHENOTYPING
The mentioned taxonomy (hierarchical classification of conditions) and phenotyping (identifying of the physical characteristics—symptoms and signs—and mechanisms of the diseases within the taxonomy) is important.
Appropriate taxonomy and phenotyping is a prerequisite for epidemiology, diagnosis, management, and prognosis. With traditional management of pelvic pain, there has been a tendency to use inappropriate treatments with inappropriate expectations; the result is increased distress and a worse prognosis.
8
Currently, it is not unusual for inappropriate treatments to be instigated due to a failure to understand the pain syndromes.
1 For example, classic mismanagement would be the recurrent use of antibiotics or the use of surgery for the complaint of pain. Whereas surgery may have a role for functional reasons (e.g., incontinence), there is a serious debate about its use for pain management. Appropriate taxonomy and phenotyping allows appropriate expectation of both the patient and those providing medical care. Unfortunately, many patients and doctors have inappropriate expectations for treatments aimed at cure. This produces distress, and the increased distress is associated with a worse prognosis.
13,14
An appropriate taxonomy and phenotyping encourages interdisciplinary and multidisciplinary management. In the case of most pelvic pain syndromes, where there may be a reduction in symptoms with appropriate treatment, cure is often not possible. The best outcomes in terms of reduced disability and improved quality of life will come from a symptom management approach involving multiple interdisciplinary teams (e.g., urology, pain
medicine, neurology) and multiple members of the team (e.g., nurses, doctors, psychologists, physiotherapists). This is a standard approach for other pain syndromes and should be the standard approach for the urogenital/pelvic pain syndromes.